Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>IDH2+ R/R* > Treatment > Co: USA. C. Enasidenib > Companion Diagnostics>

---

Companion Diagnostics>'s subsections
>(*) USA Approval Date: 2017. 08.01
>(*) USA Availability By:
>Company
>TradeMark
>TradeMark Web-Site

Companion Diagnostics>'s products
This section has no products